CEPI begins first human trial of Bundibugyo Ebola vaccine
CEPI is launching the first human safety and immune response trial for a new Bundibugyo Ebola vaccine, potentially marking a crucial step in preventing future outbreaks.
Agency Report
Premium Times Nigeria · 1h ago · 1 min read
The Phase I clinical trial, known as BD-Ebov, will evaluate the safety of the experimental vaccine and its ability to stimulate immune responses in healthy adult volunteers. The post CEPI begins first human trial of Bundibugyo Ebola vaccine appeared first on Premium Times Nigeria .
#ebolaVaccine#clinicalTrials#globalHealth
Finished reading? Claim your XP.
Earn 70 XP + streak bonus
